News2IN
Top Stories

Written by news2in

New Delhi: The extended gap at least 12 weeks between two doses of covishield has resulted in a better immune response among the majority of vaccinated Indians, subsidizing every direct requirement for booster shots, official assessment of real life data from the sero prevalence study is displayed.
Citing findings, experts also ruled out the possibility of reducing the gap between two covishield shots.
This finding will soon be submitted to the Ministry of Health for further consideration for policy making, the official source said.
“We have reviewed data regularly and now because large-scale data are vaccinated people available, we have learned it too.
Every decision will be driven by these scientific facts,” said the source.
According to the source, there is no question to reduce the gap because the data shows that the immune response has increased with a three-month gap between two covishield doses “.
Of the total more than 112 doses of covid vaccine crore given in the country so far, 88% is covishield, vaccine Developed by the University of Oxford and Astrazencea.
This vaccine is produced locally by the Indian Serum Institute.
India currently provides a second dose of Covishield on a loophole of 12-16 weeks.
While more than 79% of the qualified adult population has received at least the first dose of the Covid vaccine, About 39% is fully vaccinated with two doses.
Although there are around 12 crore people late for the second dose, the main reason for the slow progress of the second dose coverage is also a long gap between two Jab Covishield, which is the majority of vaccinations.
When most populations qualify now covered with the first dose of vaccines and there are also shares NG adequate, several countries, and public health experts, have been written to the center asking that to reduce protection.
with two covishield doses.
However, the government has stated that every decision will be driven by scientific recommendations from experts who evaluate the same thing.
The assessment of sero prevalence data also underlines there is no direct requirement for the booster dose, a rather full vaccination is very important for long-term immunity, the source said.

About the author

news2in